Evidence map›Paper›PMID 42577561›Full record

ArticleFood science & nutrition2026

Development and Functional Evaluation of a Pharmabiotic Food Supplement Containing Microencapsulated

Pervin Soyer, A Alper Öztürk

Abstract read
In one paragraph

Article in Food science & nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Development of Pharmabiotic Gel-Serums withGels (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Pervin SoyerFaculty of Pharmacy, Department of Pharmaceutical Microbiology Anadolu University Eskisehir Turkiye.ORCID https://orcid.org/0000-0002-6258-1993
A Alper ÖztürkFaculty of Pharmacy, Department of Pharmaceutical Technology Anadolu University Eskisehir Turkiye.ORCID https://orcid.org/0000-0001-9596-0538

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral microbiome dysbiosis is associated with biofilm-related diseases, including dental caries and periodontal infections. This study aimed to develop and evaluate a pharmabiotic oral spray containing microencapsulated Lactiplantibacillus pentosus, sodium hyaluronate, and licorice (

Indexed as

Lactiplantibacillus pentosusmicroencapsulationoral spraypharmabiotic

Identifiers

PMID42577561
PMCPMC13454382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.